Filana Therapeutics FLNA
NASDAQ FLNA
$0.96 +0.02 (+1.96%)
At close: Aug 21, 2026 · 4:00 PM EDT

Filana Therapeutics (FLNA) Revenue Growth (3y) (2013)

Filana Therapeutics (FLNA) Revenue Growth (3y) (2013) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 10.17%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 10.76%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 77.85%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -25.02%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 42.02%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 59.40%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -37.68%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 76.62%
9 Royalty Pharma 27.27 Bn 26.43 Bn - 7.80%
10 Filana Therapeutics 46.00 Mn 46.00 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2013 63.87%
Sep 30, 2013 -12.22%
Jun 30, 2013 -9.65%